dagblog - Comments for "The Husband-and-Wife Team Behind The Leading Vaccine to Solve Covid-19"

we ain't see nothing yet as

artappraiser — Wed, 11 Nov 2020 21:58:39 +0000

we ain't see nothing yet as far as grievance Olympics is concerned? Once Biden is inaugurated the Trump fans are gonna steal all the shtick and add more on top? and they will be the biggest aggrieved minority group of all time, now persecuted by the courts (lookit then persecuting Bannon already) yuge! worldwide coaltion, yellow jackets in France et.al. Already had lots of practice....

Ah yes, just perused the

PeraclesPlease — Wed, 11 Nov 2020 19:31:15 +0000

In reply to geez, NCD and PP, if you want

Ah yes, just perused the Comments section of the Eva Longoria thread - we must learn to smiteth as doth the Lord. My fave was a Black guy man-Black-splaining Latinos over slavery since 1619, oblivious to Latino slavery since 1492 up to 1888, which is the rape-slavery-genocide where Latinos come from (rather than a few unmixed Spanish communities who managed not to take part in the atrocities.)

geez, NCD and PP, if you want

artappraiser — Wed, 11 Nov 2020 18:37:09 +0000

In reply to See where we are in 3 months.

geez, NCD and PP, if you want to be properly anti-racist, instead of just not racist, you have to to learn to stop being so negative about the work of persecuted minorities.

See where we are in 3 months.

PeraclesPlease — Wed, 11 Nov 2020 17:48:39 +0000

In reply to Huge drawback of the vaccine

See where we are in 3 months. This is a Minimum Viable Product, pre-alpha.

Huge drawback of the vaccine

NCD — Wed, 11 Nov 2020 16:50:06 +0000

In reply to The Husband-and-Wife Team Behind The Leading Vaccine to Solve Covid-19

Huge drawback of the vaccine is it must be stored at -94 degrees Fahrenheit until use. some have called it a vaccine for the wealthy as no on else, certainly not the poor, will ever get it. Reuters:

The main issue is that the vaccine, which is based on a novel technology that uses synthetic mRNA to activate the immune system against the virus, needs to be kept at minus 70 degrees Celsius (-94 F) or below.

“The cold chain is going to be one of the most challenging aspects of delivery of this vaccination,” said Amesh Adalja, senior scholar at Johns Hopkins Center for Health Security.

“This will be a challenge in all settings because hospitals even in big cities do not have storage facilities for a vaccine at that ultra-low temperature.”